Integrating molecular glioma classification with mechanisms of epileptogenesis (including particular mechanisms involved in GAE such as IDH and mTOR pathway alterations, glutamatergic dysregulation, and cancer neuroscience) is crucial for improving diagnosis, prognostication, and treatment. This evidence concerns the gene IDH1 and central nervous system cancer.